Craig Hopkinson

Technik-/Wissenschafts-/F&E-Leiter bei ALKERMES PLC

Vermögen: 3 Mio $ am 30.04.2024

56 Jahre

Health Technology

Consumer Services

Aktive Positionen von Craig Hopkinson

Unternehmen	Position	Beginn	Ende
ALKERMES PLC	Technik-/Wissenschafts-/F&E-Leiter	30.05.2017	-

Unternehmen	Position	Beginn	Ende
ALBIREO PHARMA, INC.	Direktor/Vorstandsmitglied	01.12.2022	02.03.2023
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Technik-/Wissenschafts-/F&E-Leiter	01.05.2017	01.01.2020
VERTEX PHARMACEUTICALS INCORPORATED	Technik-/Wissenschafts-/F&E-Leiter	01.07.2014	01.05.2017
Eisai, Inc. Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ.	Corporate Officer/Principal	01.01.2013	01.07.2014
	Präsident	01.10.2011	01.12.2012

University of the Free State

Undergraduate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	3
Undergraduate Degree	1
Corporate Officer/Principal	1

Sektoral

Health Technology	6
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
ALKERMES PLC	Health Technology
VERTEX PHARMACEUTICALS INCORPORATED	Health Technology

Private Unternehmen	3
Eisai, Inc. Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ.	Health Technology
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.	Health Technology
Alkermes, Inc. Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA.	Health Technology